首页VCEL • NASDAQ
add
Vericel Corp
昨日收盘价
$48.65
当日价格范围
$47.64 - $49.02
年度波幅
$30.18 - $53.05
市值
23.38亿 USD
平均交易量
36.84万
市盈率
5,031.38
股息率
-
主要交易所
NASDAQ
财务信息
损益表
收入
净收入
| (USD) | 2023年12月info | 年同比变化 |
|---|---|---|
收入 | 6499.60万 | 23.35% |
经营支出 | 3577.60万 | 11.23% |
净收入 | 1299.30万 | 119.40% |
净利润率 | 19.99 | 77.85% |
每股收益 | 0.26 | 100.00% |
息税折旧摊销前利润 | 1388.00万 | 94.83% |
有效税率 | 7.81% | — |
资产负债表
总资产
负债总额
| (USD) | 2023年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 1.10亿 | -8.35% |
总资产 | 3.54亿 | 29.54% |
负债总额 | 1.28亿 | 58.19% |
权益总额 | 2.26亿 | — |
发行在外的股份 | 4829.02万 | — |
市净率 | 10.31 | — |
资产回报率 | 9.48% | — |
资本回报率 | 10.55% | — |
现金流
现金净变动
| (USD) | 2023年12月info | 年同比变化 |
|---|---|---|
净收入 | 1299.30万 | 119.40% |
来自运营的现金 | 1008.60万 | 44.60% |
投资现金 | -808.80万 | 62.78% |
融资现金 | 130.70万 | 116.03% |
现金净变动 | 330.50万 | 123.36% |
自由现金流 | 561.34万 | -51.77% |
简介
Vericel Corporation is a public, American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before.
In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts. Wikipedia
CEO
成立时间
1989
网站
员工数量
314
